Kanal Singh

Convalescent Plasma for the Treatment of COVID-19: Perspectives of the National Institutes of Health COVID-19 Treatment Guidelines Panel

Alice K. Pau, Judith A. Aberg, Jason Baker et al. · Annals of Internal Medicine · 2020 · 63 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +10

Long-term persistence of transcriptionally active ‘defective’ HIV-1 proviruses: implications for persistent immune activation during antiretroviral therapy

Kanal Singh, Ven Natarajan, Robin Dewar et al. · AIDS · 2023 · 57 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

National Institutes of Health COVID-19 Treatment Guidelines Panel: Perspectives and Lessons Learned

Roy M. Gulick, Alice K. Pau, Eric S. Daar et al. · Annals of Internal Medicine · 2024 · 43 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Developing Treatment Guidelines During a Pandemic Health Crisis: Lessons Learned From COVID-19

Safia Kuriakose, Kanal Singh, Alice K. Pau et al. · Annals of Internal Medicine · 2021 · 24 citations · Full text

Pharmacy, Health Policy, Pharmacotherapy +12

A Non-Leaky Artemis-Deficient Mouse That Accurately Models the Human Severe Combined Immune Deficiency Phenotype, Including Resistance to Hematopoietic Stem Cell Transplantation

Zheng Xiao, Elizabeth Dunn, Kanal Singh et al. · Biology of Blood and Marrow Transplantation · 2009 · 18 citations · Full text

Life Sciences, Hematology, Immunology +14